Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Global survival

Outcome Description:

Overall survival will be determined from the date of commencement of treatment to date of death, regardless of the cause of death. In patients who did not die at the time of final analysis will use the date of last contact.

Outcome Time Frame:

from inclusion until at least 6 months after

Safety Issue:

Yes

Principal Investigator

Oscar G Arrieta, MD Msc

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mexico. Nacional Cancer Institute

Authority:

Mexico: Ethics Committee

Study ID:

PACO2012

NCT ID:

NCT01631565

Start Date:

May 2012

Completion Date:

September 2013

Related Keywords:

• Lung Neoplasms
• Palliative Care
• Survival
• Quality of life
• Neoplasms
• Lung Neoplasms